![](https://geneva-network.com/wp-content/uploads/2016/01/globe-550x350.jpg)
The innovation paradox: why complex drug research is not being rewarded
The patent system in the US and the EU is not rewarding complex research into treatments for a host of prevalent diseases and conditions, and reforms are going in the wrong direction, says Erika Lietzan of the University of Missouri School of Law.